Melanogenesis is a physiological process resulting in the synthesis of melanin pigments which play a crucial protective role against skin photocarcinogenesis. In vivo, solar ultraviolet light triggers the secretion of numerous keratinocyte-derived factors that are implicated in the regulation of melanogenesis. Among these, tumor necrosis factor a (TNFa), a cytokine implicated in the pro-in¯ammatory response, down-regulates pigment synthesis in vitro. In this report, we aimed to determine the molecular mechanisms by which this cytokine inhibits melanogenesis in B16 melanoma cells. First, we show that TNFa inhibits the activity and protein expression of tyrosinase which is the key enzyme of melanogenesis. Further, we demonstrate that this eect is subsequent to a down-regulation of the tyrosinase promoter activity in both basal and cAMP-induced melanogenesis. Finally, we present evidence indicating that the inhibitory eect of TNFa on melanogenesis is dependent on nuclear factor kappa B (NFkB) activation. Indeed, overexpression of this transcription factor in B16 cells is sucient to inhibit tyrosinase promoter activity. Furthermore, a mutant of inhibitory kappa B (IkB), that prevents NFkB activation, is able to revert the eect of TNFa on the tyrosinase promoter activity. Taken together, our results clarify the mechanisms by which TNFa inhibits pigmentation and point out the key role of NFkB in the regulation of melanogenesis.
Introduction
In mammals, skin and hair color is due to melanin pigments that are synthesized by melanocytes within specialized organelles called melanosomes. Melanin synthesis or melanogenesis is controlled by at least three enzymes: tyrosinase, TRP1, and TRP2 among which tyrosinase has a key role since it catalyzes the ®rst and rate limiting steps, the hydroxylation of tyrosine to L-DOPA and the oxidation of L-DOPA in dopaquinone. In vivo, melanogenesis is controlled by a complex network of regulatory processes which involve two epidermal cell types, melanocytes and keratinocytes. The main physiological stimulus of melanogenesis is the ultraviolet radiation of solar light which can act directly on melanocytes or indirectly through the release of keratinocyte-derived factors such as aMSH (a-melanocyte stimulating hormone), a potent inducer of melanogenesis both in vivo and in vitro (Levine et al., 1991; Hunt et al., 1994) . The mechanism by which aMSH stimulates melanogenesis is now well established. This hormone binds to a speci®c melanocortin receptor (MC-1R) coupled to an a s type G protein, resulting in the stimulation of adenylate cyclase activity and in an increase in cAMP levels. The cAMP pathway plays a pivotal role in the regulation of melanogenesis since the eect of aMSH can be mimicked by cAMP elevating agents including cholera toxin, forskolin and IBMX (O'Keefe and Cuatrecasas, 1974; Englaro et al., 1995) . aMSH as well as other cAMP elevating agents increases the expression of melanogenic enzymes, in particular that of tyrosinase, through a transcriptional mechanism which involves micropthalmia a basic-helix-loop helix tissue speci®c transcription factor (Bertolotto et al., 1996) .
TNFa, a pro-in¯ammatory cytokine, is produced by many cell types, including macrophages, lymphocytes, ®broblasts and keratinocytes, in response to inflammation, infection, and other environmental stresses (Tracey and Cerami, 1993; Kock et al., 1990) . TNFa induces a heterogeneous array of biological eects. It may elicit cell proliferation, dierentiation or apoptosis according to the cell type. TNFa, as a trimeric ligand, binds to TNF receptor R1 (p55) or R2 (p75). However, most of the biological responses of TNFa are thought to be mediated through TNF-R1 (Vandenabeele et al., 1995) .
Exposure to TNFa triggers numerous molecular events in cells including the activation of AP-1 (Brenner et al., 1989) and NFkB/Rel transcription factors (Osborn et al., 1989) . TNFa-induced AP-1 activity is mediated through the activation of the stress kinases pathway (MEKK, JNK and p38) (Karin, 1995) , while NFkB stimulation results from IkB kinase activation (DiDonato et al., 1996) . In resting cells, IkB speci®cally sequesters NFkB in the cytoplasm. After stimulation, IkB is phosphorylated and targeted to the proteasome for its degradation thereby leading to NFkB release and translocation to the nucleus. NFkB/Rel transcription factors are composed of ®ve distinct DNA-binding subunits, called p50, p52, p65/RelA, c-Rel and Rel-B (Liou and Baltimore, 1993) . These dierent family members can associate in various homo-or heterodimers, but p50/p50 and p50/p65 dimer combination are the most commonly activated in response to numerous stimuli (Baeuerle and Henkel, 1994) . TNF-R1 contains in its cytoplasmic region a speci®c domain, called the`death domain', that recruits an adaptator protein named TRADD (for TNF receptor associated death domain). Association of TRADD with the death domain of the receptor leads to recruitment of TRAF2 (for TNF receptor associated factor 2) and RIP (for receptorinteracting protein) which is a serine/threonine kinase (Yuan, 1997) . It has been shown that activation of AP-1 and NFkB by TNFa are mediated via TRAF2 and RIP recruitment. Apoptosis appears to be mediated by a dierent pathway which involves a protein called Fas Associated Death Domain (FADD), also recruited by TRADD (Liu et al., 1996) .
In epidermis ultraviolet radiation triggers the secretion by keratinocytes of aMSH and TNFa that elicit antagonistic eects on melanogenesis (Chakraborty et al., 1996; Kock et al., 1990) . Indeed, TNFa has been shown to display a strong inhibitory eect on the melanization process in human melanocytes (Swope et al., 1991) . To understand the molecular mechanisms by which TNFa mediates this response, we studied the eect of this cytokine on basal and cAMP-induced melanogenesis in B16 melanoma cells. We have found that TNFa induced a down-regulation of both the level of tyrosinase protein and tyrosinase gene expression. This inhibitory eect is not due to the induction of apoptosis and does not appear to be mediated through the activation of the stress activated kinases and AP-1 pathway. Finally, we show that TNFa-induced downregulation of the tyrosinase gene expression is dependent on NFkB activation, demonstrating that NFkB mediates TNFa-induced inhibition of melanogenesis.
Results

TNFa inhibits tyrosinase expression
First, we measured the inhibitory eect of TNFa on the tyrosinase activity in B16 melanoma cells. Cells were treated for 48 h with forskolin, TNFa or forskolin plus TNFa and the DOPA-oxidase activity, the second speci®c activity of tyrosinase, was assayed in a cell free system. As shown in Figure 1A , forskolin stimulated the tyrosinase activity more than 20-fold. Exposure to TNFa alone or in combination with forskolin led to a 50% inhibition of the basal and cAMP-induced tyrosinase activity. Further, Western blot analysis showed that TNFa induced also a decrease in the tyrosinase protein levels in both basal and cAMP-induced conditions ( Figure  1B) .
Then, we investigated the eect of TNFa on tyrosinase gene transcription. For this, we used a reporter plasmid containing 2.2 kb of the tyrosinase gene promoter cloned upstream of the luciferase gene, which has been shown to be responsive to cAMP elevating agents (Bertolotto et al., 1996) . B16 cells were transiently transfected with this plasmid, treated as indicated and luciferase activity was measured ( Figure  1C ). Forskolin stimulated the promoter activity 15-fold, whereas TNFa inhibited luciferase activity in both basal and forskolin-treated cells. This result demonstrates that inhibition of melanogenesis by TNFa results from an inhibition of the tyrosinase gene transcription thereby leading to a decrease in both tyrosinase activity and protein level. TNFa does not induce apoptosis of B16 melanoma cells TNFa elicits a large array of biological responses including apoptosis. Hence, we wished to investigate whether the inhibitory eect of TNFa on melanogenesis re¯ected apoptotic cell death. After exposure of B16 cells to TNFa for 48 h, no apoptosis was detected by the TUNEL method ( Figure 2b ). We observed only a slight decrease in cell number (10%). By contrast, exposure of NIH3T3 cells to TNFa resulted in apoptosis after 12 h ( Figure 2d , cells with red nucleus indicated by arrows), and in a 50% decrease in cell number after 48 h (not shown). Thus, the inhibition of melanogenesis by TNFa was not a result of induction of apoptosis.
Eect of TNFa on AP-1 activation pathway
TNFa has been shown to activate MAP kinases (ERK1 and ERK2) (Winston et al., 1995) and stress activated protein (SAP) kinases (JNK and p38) (Minden et al., 1994 Raingeaud et al., 1995 that have been involved in the activation of AP-1 transcription factor (Karin, 1995) . We therefore studied the eect of TNFa on AP-1 activation pathway. First, B16 cells were treated with TPA, as a positive control, forskolin, TNFa and forskolin plus TNFa for 10 min. Then kinase assays were performed after immunoprecipitation with anti-ERK1 and anti-ERK2 speci®c antibodies using myelin basic protein (MBP) as a substrate. The phosphorylated product was visualized by SDS ± PAGE and autoradiography ( Figure 3A ). As we have previously reported, TPA and forskolin stimulated ERK1 and ERK2 activities (Englaro et al., 1995) , whereas TNFa did not. Next, we studied the eect of TNFa on the SAP kinases, JNK and p38 kinase. B16 cells were treated as indicated above and anisomycin was used as a positive control. JNK and p38 kinase activities were measured by immune complex kinase assays using GST-ATF2 as a substrate . Anisomycin strongly stimulated both JNK and p38 activity ( Figure 3B ). Forskolin did not stimulate JNK and p38 activity, while TNF induced a weak activation of both SAP Figure 2 B16 melanoma cells are resistant to TNFa-mediated apoptosis. Apoptotic cell death was detected by the TUNEL method. B16 cells and NIH3T3 cells, grown in 2% serum containing medium were incubated respectively for 48 and 12 h with 50 ng/ml TNFa (b,d) or left untreated (a,c). Apoptosis detection was performed as described in the Material and methods section. Then cells were photographed using light microscopy. Representative ®elds are shown. Bar in`a' represents 40 mm Figure 3 Eect of TNFa on the AP-1 pathway in B16 melanoma cells. (A) B16 cells were treated with 16 nM TPA, 10 mM forskolin (FK), 50 ng/ml TNFa and forskolin plus TNFa for 10 min. Then ERK1 and ERK2 were immunoprecipitated and their kinase activity was measured in presence of [g 32 P]ATP using MBP as a substrate. (B) JNK and p38 kinase activities were determined in the same way except that cells were treated with 10 mg/ml anisomycin as a positive control and GST-ATF2 was used as a substrate. (C) DNA-binding activity of 10 mg proteins from the various cell extracts was measured by EMSA using 32 P-endlabeled oligonucleotide representing AP-1 binding sequence (5'-CGCTTGATGACTCAGCCGGAA-3').`B', Basal activity kinases. Then, we performed electromobility shift assays to evaluate the eects of TNFa on AP-1 DNA-binding activity. Using an oligonucleotide containing the binding sequence for AP-1, we observed the formation of a speci®c complex with nuclear proteins extracted from B16 cells treated with TPA ( Figure 3C ). TNFa and forskolin weakly stimulated the AP-1 DNA binding activity as compared to TPA. Moreover, TNFa did not increase AP-1 transcriptional activity since it did not modify the expression of a luciferase reporter plasmid containing two AP-1 binding sites upstream of the rat prolactin gene minimal promoter (data not shown). Thus, consistent with the absence of an eect on ERKs and the weak eect on SAP kinase activities, TNFa is a poor activator of the AP-1 pathway in B16 melanoma cells.
TNFa stimulates the DNA-binding activity of NFkB in B16 cells
TNFa has been described to also activate NFkB (Osborn et al., 1989) thereby providing a protective eect against TNFa-induced apoptosis (Liu et al., 1996) . We therefore investigated the eect of TNFa on NFkB DNA-binding activity (Figure 4 ). Using the consensus binding sequence for NFkB, we observed that TNFa strongly stimulated the binding of NFkB to its target sequence, whereas TPA, which is known to activate NFkB in other cell types (Imbert et al., 1996) was rather a poor inducer of NFkB DNA binding activity in B16 cells. Noteworthy, forskolin did not aect NFkB binding. The very ecient activation of NFkB induced by TNFa in B16 melanoma cells, prompted us to investigate the role of this transcription factor in the anti-melanogenic eect of TNFa.
NFkB activation mediates TNFa-induced inhibition of tyrosinase gene expression B16 cells were transiently co-transfected with the luciferase gene under the control of the 2.2 Kb segment of the tyrosinase gene promoter and an expression vector empty or encoding the p50 and p65 subunits of NFkB. As an external control, a reporter plasmid containing the SV40 promoter upstream of a luciferase gene was also transfected with the coding vectors to test for the speci®city of the response. As shown in Figure 5A overexpression of NFkB led to a strong decrease in forskolin-induced tyrosinase gene expression. It also reduced the basal promoter activity. This eect was speci®c since no signi®cant variation in the luciferase activity of SV40 promoter was observed (not shown). Thus, this result demonstrates that overexpression of NFkB mimicks the eect of TNFa on tyrosinase transcription.
Finally, to con®rm the role of NFkB in TNFa response, we used a mutant of IkB (S32/36A) which lacks the speci®c phosphorylation sites and thus cannot be degraded (Traenckner et al., 1995) . This mutation confers a constitutive inactivation of NFkB by retaining it in the cytoplasm. Using a luciferase reporter plasmid containing six NFkB sites upstream of a minimal thymidine kinase promoter, we observed that TNFa increased luciferase expression (17+3-fold). When IkB (S32/36A) was co-transfected the eect of TNFa was dramatically reduced (4.5+1-fold) demonstrating thereby the dominant negative eect of this mutant. The eect of IkB (S32/36A) on the tyrosinase gene expression was then measured as described above. We observed that in cells transiently expressing IkB (S32/36A), the inhibitory eect of TNFa on tyrosinase promoter activity was reverted ( Figure 5B ). Thus, TNFa lost its ability to inhibit both basal and cAMPinduced tyrosinase gene expression demonstrating the critical role of NFkB in the TNFa-mediated inhibition of melanogenesis.
Discussion
In this report, we investigated the molecular mechanisms by which TNFa elicits its inhibitory eects on melanogenesis. We demonstrated that TNFa downregulates tyrosinase expression and tyrosinase promoter activity, strongly suggesting that TNFa decreases melanogenesis through an inhibition of tyrosinase gene transcription. Then, among the dierent pathways activated by TNFa, including apoptosis, AP-1 and NFkB pathways, we wished to identify the eector function involved in the inhibition of tyrosinase gene transcription by TNFa.
First, we observed that, in our experimental conditions, TNFa is not an inducer of apoptosis. Further, the absence of MAP kinases activation and the weak eect of TNFa on SAP kinases resulting in a barely detectable AP-1 activation, have prompted us to eliminate the possibility of a role for the MAPK/ SAPK/AP-1 cascade in TNFa-induced melanogenesis down-regulation. In agreement with this, we have Figure 4 TNFa activates NFkB in B16 melanoma cells. B16 cells were treated with 16 nM TPA, 10 mM forskolin (FK), 50 ng/ml TNFa or forskolin plus TNFa for 30 min. DNA-binding activity of 10 mg proteins from the various cell extracts was measured by EMSA using 32 P-end-labeled oligonucleotide representing NFkB. Speci®c binding of NFkB was evaluated using a 50-fold molar excess of unlabeled NFkB consensus binding sequence (506). NS', non speci®c observed that neither the p38 inhibitor, SB 203580 (Lee et al., 1994) , nor dominant negative mutants of the SAPK pathway have any eect on the TNFa inhibition of the melanogenic process (data not shown). Hence, it appears that neither apoptosis, nor the AP-1 pathway mediate the TNFa eect in B16 cells.
The third pathway activated by TNFa in numerous cell lines leads to the up-regulation of NFkB (Osborn et al., 1989) . In our cell system, we observed that TNFa strongly increases the binding of this transcription factor to its target sequence. Interestingly, it has been reported that NFkB activation is a critical event in protecting cells from TNFa-induced apoptosis, by stimulating the expression of survival genes. Hence, activation of NFkB in B16 cells could explain the resistance of these cells to TNFa-induced apoptosis. Further, this strong activation prompted us to evaluate the role of this transcription factor in TNFa-induced inhibition of melanogenesis. Overexpression of the p50 and p65 subunits of NFkB is sucient to repress the tyrosinase promoter activity. Moreover, a dominant negative mutant of IkB that cannot be phosphorylated and degraded, blocks NFkB activation and is able to prevent the TNFa-induced inhibition of the tyrosinase promoter activity. These experiments show that NFkB is a negative regulator of the tyrosinase promoter activity and demonstrate that the inhibition of the tyrosinase promoter activity by TNFa is mediated through NFkB activation. These results emphasize the role of NFkB in the regulation of tyrosinase gene expression and of melanogenesis.
How NFkB inhibits tyrosinase gene expression remains to be elucidated. Indeed, NFkB cannot act directly on the tyrosinase gene promoter since no consensus binding sites for this transcription factor are present in the 2.2 kb tyrosinase promoter sequence. It seems more likely that the down-regulation of the tyrosinase gene expression is an indirect mechanism mediated by other transcription factors that could be regulated by NFkB. Consistent with this hypothesis, TNFa inhibits the expression of human a2(I) collagen gene by regulating the activity of unidenti®ed transcriptional complexes that recognize both positive and negative cis-acting elements in the a2(I) collagen gene promoter (Inagaki et al., 1995) . Alternatively, NFkB may regulate the expression or the activity of microphthalmia, a b-HLH transcription factor that plays a crucial role in the regulation of tyrosinase expression (Bertolotto et al., 1996) . Noteworthy, NFkB is known to activate the expression of numerous cytokines implicated in in¯ammatory processes (Baeuerle and Henkel, 1994) . Some of these cytokines, including IL-1 and IL-6 are secreted by melanoma cells (Bennicelli and Guerry, 1993) and have been reported to inhibit melanogenesis in both murine melanoma cells and human melanocytes (Swope et al., 1989 (Swope et al., , 1991 . Hence, TNFa through NFkB activation, could be involved in an autocrine regulation of the melanogenesis process. Further, we cannot rule out the possibility that NFkB does not act only on tyrosinase gene transcription but also regulates tyrosinase half-life by increasing its rate of degradation. In agreement with this hypothesis, MartinezEsparza et al. (1997) have reported that TGFb-induced decrease in melanogenesis is caused by an augmentation of the tyrosinase degradation rate. Overexpression of NFkB (p50/p65) is sucient to induce down-regulation of tyrosinase promoter activity. B16 cells were co-transfected with 2.2 pMT luciferase reporter plasmid and either with expression vectors coding for p50 and p65 monomers of NFkB (A) or expression vector coding for IkB (S32/36A) (B). As a control, 2.2 pMT luciferase reporter plasmid was co-transfected with an empty expression vector (vector). After transfection cells were left untreated or incubated with 20 mM forskolin (FK), 50 ng/ml TNFa and forskolin plus TNFa as indicated during 48 h. Then cells were solubilized and luciferase activity was assayed. The results were expressed as fold stimulation of the basal luciferase activity from unstimulated cells. Data are means+s.e. of three experiments performed in triplicate Interestingly, TNFa production by keratinocytes is increased after UV irradiation of skin (Oxholm et al., 1988 ). This appears contradictory with the inhibitory eect of TNFa on tyrosinase since UV irradiation is a physiological inducer of melanogenesis. However, in addition to TNFa, UV induces secretion of many factors by epidermal cells including aMSH, endothelin-1 that stimulate melanization (Gilchrest et al., 1996) . TNFa may therefore participate in a negative feedback loop that regulates UV-induced melanogenesis thereby preventing over-production of melanins that would be noxious for melanocytes.
In summary, our data strongly suggest that TNFa through NFkB activation down-regulates tyrosinase gene expression leading to an inhibition of melanogenesis. These results emphasize a new mechanism for melanogenesis regulation which involves the transcription factor NFkB as a negative eector. This regulatory process could play a crucial role in the homeostasis of epidermal melanocytes during UVinduced pigmentation.
Material and methods
Material
Forskolin, TPA, L-DOPA, 4-(2-aminoethyl)-benzene-sulfonyl¯uoride (AEBSF), aprotinin and leupeptin were purchased from Sigma (St Louis, MO, USA). Dulbecco's modi®ed Eagles medium (DMEM), lipofectamine reagent and optimem medium were from Gibco BRL (Paisley, Scotland, UK). Recombinant mouse tumor necrosis factor alpha was from R&D Systems (Abington, UK). Polyclonal rabbit antiserum to human tyrosinase (PEP-7) was provided by Dr V Hearing (Bethesda, USA). Antisera to ERK1 and ERK2 were generous gifts from Dr E Van Obberghen (Nice, France). Oligonucleotides presenting the consensus binding sites for NFkB and AP-1 were synthesized by Eurogentec (Seraing, Belgium). The NFkB binding sequence, corresponding to the site present in the human IL-2 promoter, is: 5'-GATCCAAGGGACTTTCCATG-3'. The AP-1 binding sequence consists in: 5'-CGCTTGATGACTCAGCCG-GAA-3'. Expression vectors encoding p50 and p65 subunits of NFkB and the mutant of IkB (S32/36A) were previously described (Traenckner et al., 1995) .
Cell culture
B-16/F1 murine melanoma cells and NIH3T3 cells were cultured in DMEM with 7% fetal calf serum (Hyclone Laboratories) and penicillin/streptomycin (100 IU/ 50 mg/ ml) in a humidi®ed atmosphere containing 5% CO 2 at 378C.
Determination of tyrosinase activity
Tyrosinase activity was estimated by measuring the rate of oxidation of L-DOPA (Takahashi and Parsons, 1992) . Cells were plated in 6-well dishes (35 mm) and treated as indicated for 48 h in DMEM 2% FCS. Then cells were washed in ice cold PBS and lysed in 100 ml of 0.1 M phosphate buer, pH 6.8, containing 1% (v/v) Triton X-100, 2 mg/ml aprotinin, 10 mM leupeptin and 1 mM AEBSF. Cellular extracts were clari®ed by centrifugation at 13 000 g for 5 min. The tyrosinase substrate L-DOPA (2 mg/ml) was prepared in the same lysis phosphate buer (without triton). Forty ml of each extract were added to a 96-well plate and the enzymatic assay was started by adding 100 ml of L-DOPA solution at 378C. Control wells contained only 40 ml of lysis buer. Absorbance at 570 nm was read every 10 min for at least 1 h at 378C using a micro plate reader (Dynatech Laboratories). The blank was substracted from each absorbance value and a plot of absorbance against time was represented for each condition. The ®nal activity was expressed in DDO/min/mg proteins for each condition.
Western blotting
Cellular extracts were prepared as described above and equal amounts of protein were separated by SDS ± PAGE in a 10% acrylamide gel. Proteins were transferred to a Hybond-C extra membrane (Amersham, UK) and the blot was probed with the PEP-7 polyclonal antibody (directed against tyrosinase) and with an anti-ERK1 polyclonal antibody (to test for the equal loading of the gel). Then proteins were visualized by the Amersham ECL system.
Detection of apoptosis
B16-F1 melanoma cells and NIH3T3 cells were cultured on glass slides in DMEM with 2% serum and incubated with 50 ng/ml TNFa during 12, 24 and 48 h or left untreated. Then cell apoptosis was detected by TUNEL method (Gavrieli et al., 1992) using the ApopDetek kit (Enzo Diagnostics, USA). Brie¯y, cells were ®xed with a 3% paraformaldehyde solution before permeabilization with 0.1% Triton X-100. Cells were incubated with biotinlabelled nucleotides and terminal deoxynucleotide transferase for 1 h at 378C, followed by incubation with avidin conjugated-peroxidase. 9-amino 3-ethyl carbazole was used as a substrate for developing the reaction. Then cells were counter-stained with hematoxylin blue to visualize only the apoptotic cells (red nucleus).
Kinase assay
For determination of the ERKs activities, clari®ed extracts, prepared in the following lysis buer: 50 mM HEPES pH 7.4, 150 mM NaCl, 100 mM NaF, 10 mM EDTA, 10 mM Na 4 P 2 O 7 , 2 mM Na 3 VO 4 , 1% Triton X-100, supplemented with protease inhibitors: aprotinin (2 mg/ ml), leupeptin (20 mM) and AEBSF (1 mM) were incubated for 2 h at 48C with ERK1 or ERK2 antibodies preadsorbed to protein A-sepharose. Immune complexes were washed twice with lysis buer and twice with HNTG buer (50 mM HEPES pH 7.4, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol and 0.2 mM Na 3 VO 4 ). Pellets were resuspended in 50 ml of HNTG buer supplemented with 30 mM magnesium acetate and 0.2 mg/ml myelin basic protein.
Reactions were initiated at room temperature by the addition of 3 mCi [g-32 P]ATP (30 Ci/mmol) and stopped after 45 min by adding Laemmli sample buer. Samples were then boiled for 5 min and proteins separated by SDS ± PAGE on a 12.5% acrylamide gel. Incorporation of 32 P was visualized by autoradiography.
For JNK and p38 kinase assays, immune complexes were washed twice with lysis buer and twice with kinase buer (25 mM HEPES pH 7.4, 25 mM b-glycerophosphate, 25 mM MgCl 2 , 0.1 mM Na 3 VO 4 , 0.5 mM dithiothreitol). Kinase assays were carried out in a ®nal volume of 50 ml of kinase assay buer with 10 mg GST-ATF2 (residues 1 ± 109) as substrate and 3 mCi [g-32 P]ATP (30 Ci/mmol). Then procedures were the same as described above except that the samples were resolved on a 10% acrylamide gel.
Transfection experiments and luciferase activity B16 melanoma cells, plated in 24-well dishes (15 mm), were transfected using the lipofectamine system according to recommendation of the manufacturer (Gibco ± BRL). The reporter plasmid used consists of a 2.2 Kb fragment of the mouse tyrosinase gene promoter cloned upstream of the luciferase gene and named 2.2 pMT-Luc (Bertolotto et al., 1996) . For the determination of TNFa eect on tyrosinase gene promoter activity, 0.25 mg per well of the reporter plasmid were transfected with 0.05 mg of pCMVbGal (Promega) to control for the variability in transfection eciency. In the experiments with expression vectors coding for NFkB (p50/p65) and IkB (S32/36A), transfections were performed in the same conditions using 0.25 mg of the reporter plasmid and 0.25 mg of the expression vector, empty or containing the coding sequence of the dierent mutants. As an external control, 0.25 mg of a luciferase reporter plasmid containing the SV-40 promoter was co-transfected with the expression vectors to control for the speci®city of the response. Twenty-four hours before the luciferase assay, cells were treated with forskolin, TNFa or forskolin plus TNFa. Then, cells were washed with a saline phosphate buer and lysed with 25 mM Tris-phosphate (pH 7.8) buer containing 1% Triton X-100, 2 mM EDTA and 2 mM DTT. Soluble extracts were harvested and assayed for luciferase and bgalactosidase activity. All transfections were repeated at least ®ve times using dierent plasmid preparations and gave similar results.
Electromobility shift assay
Serum-starved B16 melanoma cells were stimulated as indicated for 30 min for NFkB or 1 h for AP-1. Then cellular extracts were prepared by scraping cells in the following buer: 20 mM HEPES (pH 7.9), 350 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM dithiothreitol, 0.1 mM EGTA, 20% glycerol, 1% Nonidet P 40, 1 mM AEBSF, 2 mg/ml aprotinin and 10 mM leupeptin. In vitro binding reactions of NFkB and AP-1 in a total volume of 25 ml were performed by incubation of 5 mg of nuclear extracts in a binding buer containing 10 mM HEPES (pH 7.5), 50 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 1 mM MgCl 2 5% glycerol, 2 mg poly (dI-dC) and 0.4 mg/ml salmon sperm DNA. After 10 min of pre-incubation on ice, 50 000 ± 100 000 c.p.m. of 32 P-end-labeled oligonucleotide probe were added and the binding reaction was allowed to proceed for 20 min at room temperature. Then DNAprotein complexes were resolved by electrophoresis on TAE-4% polyacrylamide gels at 48C, dried and autoradiographed. When indicated, an excess of cold competitor oligonucleotides was added during the preincubation.
